Brief: Oramed Reports Third Quarter 2022 Financial Results
Nov 10 (Reuters) - Oramed Pharmaceuticals Inc ORMP.O :
* ORAMED REPORTS THIRD QUARTER 2022 FINANCIAL RESULTS
* ORAMED PHARMACEUTICALS INC - QTRLY LOSS PER SHARE $0.18
Source text for Eikon: ID:nPnchHRFa
Further company coverage: ORMP.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Oramed Pharmaceuticals
See all newsBrief: Nano Dimension Appoints Nadav Kidron To Board Of Directors To Chair Strategy And Capital Allocation Committee
Oramed Pharmaceuticals Inc expected to post earnings of 43 cents a share - Earnings Preview
Brief: Oramed And Lifeward Announce Strategic Transaction
Brief: Oramed Receives $18 Million Payment From Scilex Holdings
Brief: Oramed Reports Fiscal Third Quarter 2025 Financial Results